Vlerick Expertise in Healthcare

 

16 results Number of Results per Page
  1. IT roadmap for Belgian hospitals

    An IT roadmap for hospitals: one size does not fit all

    Digital technologies have become indispensable in the healthcare sector. They help to achieve better and cheaper healthcare. Policymakers are focusing strongly on eHealth and collaboration between the various players in the healthcare ecosystem. Belgian hospitals have already spent too long using IT purely as a support tool, however, with all the associated consequences. It is essential for them not to miss the boat. Professor Brecht Cardoen and professor Bjorn Cumps explain how a tool which was developed in collaboration with hospitals and their stakeholders can help.

  2. Hospital network formation

    Hospital networks: quo vadis?

    Hospitals are increasingly joining forces in networks of different types, sometimes with other healthcare players. This is an unmistakable trend, but forming networks is also an important strategic decision. How can hospitals ensure the right decisions are taken, both today and tomorrow, guaranteeing a robust, resilient and versatile organisation in the long run? Changes are rapidly succeeding one another, but who knows what healthcare will be like fifteen years from now and what the best set-up would be for these networks? No one can predict the future. However, despite all the uncertainties, a scenario analysis can help in the decision-making process.

  3. UCB

    Pharma and data as gospel

    Developing drugs is a time-consuming process. In order to speed it up, the Belgian biopharmaceuticals producer UCB has decided to switch to a data-driven organisation. It was necessary to ‘convert’ the entire company to achieve this, says CIO Herman De Prins.

  4. Innovative cancer treatments: how much are we willing to pay?

    One man in three and one woman in four will develop cancer before their 75th birthday. In Belgium, cancer is the second major cause of disease burden after cardiovascular diseases and it is unlikely this will change in the foreseeable future. Increasingly better but more expensive cancer therapies are becoming available. Needless to say, in these times of austerity, the public budget for cancer treatment is under pressure. How can we ensure all patients continue to have access to these expensive but potentially life-saving medicines at a price society can afford, while at the same time encouraging pharmaceutical companies to innovate?

  5. 3D printing: a laboratory for business model research

    What should established companies do when an innovative – and potentially disruptive – new technology appears on the scene? Vlerick Business School and Sirris collaborated to develop a framework linking technology and business models. When applied to the subject of 3D printers, their model led to a number of surprising insights.

  6. Digital strategy at Merck Sharp & Dohme

    The case takes us back to October 2009, and presents a key strategic challenge facing the senior management at Merck Sharp & Dohme (MSD) BeLux: crafting the organisation’s digital strategy for the marketing and sales of its human health products in Belgium and Luxembourg.

  7. The growing importance of traceability in the health care sector

    Faulty breast implant scandals, evolutions in the legal framework, counterfeit products and patient safety are all issues that have highlighted the importance of traceability in the health care sector. The Vlerick Healthcare Supply Chain Research Network analysed in which fields the various players in the supply chain can make the greatest profits thanks to a more efficient track-and-trace process. Moreover, the main drivers and obstacles were identified.

  8. The hospital pharmacy of tomorrow

    What is the core activity of a hospital pharmacy? To provide the right drugs and other pharmaceutical products to the right patient at the right time, in the right dose and in the right condition. Currently, there is a trend towards expanding the contribution of the hospital pharmacy to include services such as information provision, advice and follow-up. ‘However, the question is whether the present organisation of the hospital pharmacy can support this trend,’ says Brecht Cardoen, Assistant Professor in Service Operations Management and head of Vlerick research centre MINOZ.

  9. co-creation

    Get ready for a co-creative economy

    In an increasingly dynamic marketplace – characterised by demanding customers, increased competition, and economic downturns – companies are starting to engage their customers in innovating their services and creating value. This doctoral dissertation provides insight into the conditions under which firms and their stakeholders can benefit from value co-creation. It also provides a unifying value co-creation framework and presents the implications of this framework for business practitioners who are interested in value co-creation as a customer engagement strategy.

  10. Case study

    Big Pharma versus small biotech: analysing the financials of Pfizer and ImmunoCellular Therapeutics

    The continued consolidation in the pharmaceutical industry has baffled many individuals. Confronted with major threats like patent losses, a depressed economic environment, soaring R&D costs, low productive development pipelines, pricing pressure and generic competition, Big Pharma has struck multibillion dollar deals like the Pfizer - Wyeth acquisition in 2009. In this case, we contrast small biotech with Big Pharma.

16 results Number of Results per Page